Novel P13K inhibitor: design and docking studies of wortmanninoid analogues (2016)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: NEOPLASIAS
ABNT
CARVALHO, Camila Felix de e TAVARES, Mauricio Temotheo e PARISE FILHO, Roberto. Novel P13K inhibitor: design and docking studies of wortmanninoid analogues. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 set. 2024. , 2016APA
Carvalho, C. F. de, Tavares, M. T., & Parise Filho, R. (2016). Novel P13K inhibitor: design and docking studies of wortmanninoid analogues. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Carvalho CF de, Tavares MT, Parise Filho R. Novel P13K inhibitor: design and docking studies of wortmanninoid analogues. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 10 res. FCF016.[citado 2024 set. 04 ]Vancouver
Carvalho CF de, Tavares MT, Parise Filho R. Novel P13K inhibitor: design and docking studies of wortmanninoid analogues. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 10 res. FCF016.[citado 2024 set. 04 ]